Atrium Health Wake Forest Baptist
Locations
Transplant Summary
Overview
The adult Stem Cell Transplant and Cellular Therapy program at Atrium Health Wake Forest Baptist is a FACT-accredited program offering autologous, related and unrelated allogeneic transplants, and Chimeric Antigen Receptor (CAR T) Cell Therapy. With a mission focused on quality and comprehensive care, the program participates in clinical trials research to meet individualized patient needs. Our experienced staff of dedicated healthcare providers offers both inpatient and outpatient transplants.This center has been performing allogeneic transplants since 1990 and has been an NMDP transplant center since August 1993.
Attending physicians
Adult - Dianna Howard, Sarada Krishmanurthy, Jonathan Lambird, John McKay, Mary Beth Seegars, Rakhee Vaidya, Matthew Wieduwilt, Anne WoffordTransplants performed
Marrow/PBSC onlyCord blood transplants
Not performedOther programs and services
The Stem Cell Transplant and Cellular Therapy Program of Atrium Health Wake Forest Baptist Comprehensive Cancer Center is a multidisciplinary adult program offering both autologous, related and unrelated allogeneic transplants, and Chimeric Antigen Receptor (CAR T) Cell Therapy. Each patient meets an assigned Transplant Nurse Coordinator at the time of consultation to help navigate the transplant journey. Comprehensive, personalized care is accomplished through our dedicated team of transplant physicians, Advanced Practice Providers (APPs), social workers, nutritionists, clinical practice pharmacists, recreational therapists and transplant-specific RNs. Discounted housing is available through the SECU Family house. A transplant orientation class is offered along with financial counseling and the support of a dedicated Cancer Patient Support Program.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 93 patients.The actual 1-year survival of these patients is 74%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 64.9% and 81.8%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
183
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow1PBSC26Cord blood0Total27Unrelated donorMarrow2PBSC66Cord blood0Total68Total allogeneicMarrow3PBSC92Cord blood0Total95AutologousMarrowBoth marrow & PBSC 88PBSC—Cord blood—Total88Total combinedMarrowBoth marrow & PBSC 183PBSC—Cord blood0Total183All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-441245-641265+3Total27Unrelated 0-18019-441545-642665+27Total68Autologous 0-18119-441045-644665+31Total88Total 0-18119-443745-648465+61Total183Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Stem Cell transplant and Cellular Therapy Program of Wake Forest Baptist Comprehensive Cancer Center
Medical Center Blvd Winston Salem, NC 27157 Physician Referrals:336-713-5440 For more information about this program: https://www.wakehealth.edu/treatment/s/stem-cell-transplant-and-cellular-therapy-program (Opens in a new tab)Overview
For autologous transplant recipients, survivorship clinic begins at 2 years post-transplant. For allogeneic transplant recipients, survivorship clinic begins at 3 years or later based on post-transplant challenges. Recipients are seen yearly for the first 6 years, then every other year. Our mission is to guide our transplant survivors toward wellness and a return to life in their communities with continued medical care, a range of resources, and a connection to support or supportive services. This includes: Monitoring for early detection of new or returning cancers — Managing late side effects related to transplant — Lifestyle coaching and tips to help reduce cancer risk — A support team with information about community resources, psychosocial care and integrative care — Access to research studies on quality of life and survivorship
Staff
Program Director:Dianna Howard, MDProgram Coordinator:Rebecca Damron, MSN, RNMedical Specialties in Program
Cancer Patient Support Program for psychology support. Other specialties are available as needed., psychiatry/psychology.Medical Services Offered
Nutrition/dietetics, social services, vaccinations, We can refer for the care of all of the above; the ones checked are available to the patient during their visit.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 6 years after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital